Wu W , Sachse FB , Gardner A , Sanguinetti MC .

R01 HL055236 NHLBI NIH HHS

	Figure 1. Concatenated tetrameric hERG1 (WT4) channels have similar biophysical and pharmacological properties as channels formed by coassembly of single WT hERG1 subunits. (A) Representative WT and WT4 hERG1 channel currents recorded at the indicated Vt (−70 to 30 mV stepped in 20-mV increments). (B) The voltage dependence of WT channel gating (upright green triangles, activation; sideways green triangles, C-type inactivation) is similar to WT4 channels (upside-down black triangles, activation [n = 6]; sideways black triangles, C-type inactivation [n = 8]). Data were fitted to Boltzmann function (smooth curves) to determine V0.5act and z values (presented in Table 1). (C) Time constants (τ deact) for fast and slow components of current deactivation for WT (green triangles, n = 10) and WT4 (black triangles, n = 11) channels at the indicated return potential (Vret). (D) Effect of 10 µM PD on WT and WT4 hERG1 channel currents elicited by 4-s step to 0 mV. Itail was measured at −70 mV. (E and F) Itest-Vt relationships in the absence (black triangles) and presence of 10 µM PD (red triangles) for oocytes injected with cRNA encoding single WT subunits (E, n = 10) or WT4 channels (F, n = 7). Currents were normalized to peak Itest (at −20 mV) measured under control conditions. (G) Effect of 10 µM ICA on currents for WT and WT4 channels. (H and I) Itest-Vt relationships in the absence (black triangles) and presence of 10 µM ICA (blue triangles) for oocytes injected with cRNA encoding single WT subunits (H, n = 5) or WT4 channels (I, n = 10). Data are expressed as mean ± SEM (n = number of oocytes).
	Figure 2. Markov modeling of hERG1 tetrameric channel currents modified by drugs PD and ICA. (A) The model comprises seven states (C0,…,C4, closed states; O, open state; I, inactivated state) coupled with the indicated rate coefficients. (B) Averaged currents (n = 4) from oocytes expressing WT4 tetramers under control conditions in response to voltage steps to the indicated Vt. (C) Simulated currents for WT4 tetramers under control conditions. (D and E) Averaged currents measured from the same oocytes as in B, after application of 30 µM PD (D), and corresponding simulated currents (E). (F and G) Averaged currents (n = 6) measured after application of 30 µM ICA (F) and corresponding simulated currents (G). Currents shown in B, D, and F were not leak subtracted.
	Figure 3. Biophysical properties of concatenated LEn/WT4−n tetrameric hERG1 channels. (A) Itest-Vt relationships. (B) Voltage dependence of activation. (C) Fully activated Itail-Vret relationships. (D) Voltage dependence of inactivation. Legend refers to all panels. Data are expressed as mean ± SEM (n = 5–12; values for V0.5 and z for activation and inactivation are presented in Table 1; n = number of oocytes).
	Figure 4. PD-induced enhancement of hERG1 current indicates cooperative subunit interactions. (A) Representative current traces recorded at 0 mV for concatenated tetramers containing zero to three WT subunits together with one to four L646E subunits, before and after 10 µM PD. (B) Effect of 10 µM PD on voltage dependence of channel activation. Itail was measured at −70 mV after pulses to the indicated Vt and normalized to Itail-max under control conditions for each channel type (n = 7–15). The symbol legend between B and E refers to data plotted in B and D–F. Control Itail-Vt relationship (black pentagons) overlaps data for LE4 channels and represents the mean of all channel types. The V0.5act and z values obtained from fitting Itail-Vt relationships to a Boltzmann function (smooth curves) before and after 10 µM PD are presented in Table 1. (C) Pulse protocol (top) used to measure fully activated Itail-Vret relationship and representative currents for WT4 channels under control conditions and after 10 µM PD as indicated. (D) Effect of 10 µM PD on Itail-Vret relationships (n = 4–9) normalized to Itail at −120 mV under control conditions for LEn/WT4−n tetramers (n = 0–4). (E) [PD]-response relationships for fold increase in Itail-max at −70 mV for different tetramers according to symbol legend shown between B and E. Data were fitted with a logistic equation to determine EC50 values and Hill coefficient, nH (see Fig. 5). (F) Plot of ΔG versus number of WT subunits contained in a concatenated tetramer. ΔG was equal to −RTlnKeq, where Keq was defined as Po/(1 − Po) at maximal effect of PD and assuming maximum Po in the absence of drug to be 0.5. Linear regression analysis was used to fit calculated data (colored symbols; solid line: y = −0.39x + 0.058; R2 = 0.96) and the relationships predicted for independent subunit transitions (▾) and cooperative subunit interactions, models 1 (▴) and 2 (•). Data are expressed as mean ± SEM (n = number of oocytes).
	Figure 5. The concentration response relationship for PD-induced increase in Itail is not dependent on the number of WT subunits in a concatenated tetramer. (A) Plot of EC50 as a function of the number of WT subunits in a tetramer. Line represents linear fit to data: y = 0.64x + 1.22 (adjusted R2 = 0.099). (B) Plot of nH as a function of number of WT subunits in a tetramer. Line represents linear fit to data: y = −0.015x + 1.24 (adjusted R2 = −0.473). In both panels, the open circle represents LE1/WT1/LE1/WT1 channels; the open square represents WT3/LE1 channels.
	Figure 6. Positioning of a single LE mutant subunit in a concatenated hERG1 tetramer does not affect biophysical properties or response to PD. (A) Representative current traces for LE1/WT3 and WT3/LE1 hERG1 channels. Pulses were applied to Vt of −70 to 30 mV in 20-mV increments. Vh was −80 mV and Vret was −70 mV. (B) Normalized Itail-Vt relationships before and after 10 µM PD. Symbol legend is the same as for C. For LE1/WT3 hERG1 channels: V0.5act = −32.1 ± 1.3 mV, z = 4.13 ± 0.14 mV (control); V0.5act = −30.1 ± 1.6 mV, z = 4.20 ± 0.07 mV (PD; n = 11). For WT3/LE1 hERG1 channels: V0.5act = −29.1 ± 1.5 mV, z = 3.36 ± 0.21 mV (control); V0.5act = −27.1 ± 1.3 mV, z = 3.44 ± 0.16 mV (PD; n = 4). (C) Normalized fully activated Itail-Vret relationships determined before and after 10 µM PD. (D) [PD]-response relationships for LE1/WT3 hERG1 channels (EC50 = 4.6 µM, nH = 1.1; n = 6–9) and WT3/LE1 hERG channels (EC50 = 4.8 µM, nH = 1.4; n = 4). Data are expressed as mean ± SEM (n = number of oocytes).
	Figure 7. Biophysical properties of concatenated FLn/WT4−n tetrameric hERG1 channels. (A) Representative current traces for concatenated tetramers containing zero to three WT subunits together with one to four F557L subunits. Pulses were applied to Vt of −70 to 30 mV in 20-mV increments. Vh was −80 mV and Vret was −70 mV. (B) Itest-Vt relationships for FLn/WT4−n tetrameric hERG1 channels. (C) Voltage dependence of activation. (D) Fully activated Itail-Vret relationships. (E) Voltage dependence of inactivation. The symbol legend refers to B–E. Data are expressed as mean ± SEM (n = 3–12). Values for V0.5 and z for activation and inactivation are presented in Table S2.
	Figure 8. Concentration- and voltage-dependent effects of ICA on Itest. (A) Concentration-dependent increase in Itest measured at 20 mV by ICA for WT4 and FL1/WT1/FL2 hERG1 concatenated channels. Data were fitted with a logistic equation (smooth curves). For WT4 channels: EC50 = 9.1 µM, nH = 1.7 (n = 6–9); for FL1/WT1/FL2 channels: EC50 = 11.8 µM, nH = 2.0 (n = 6–10). (B) Fold increase in Itest by 30 µM ICA as a function of Vt (n = 3–8). Data are expressed as mean ± SEM (n = number of oocytes).
	Figure 9. Attenuation of hERG1 inactivation by ICA exhibits positive cooperativity. (A) Representative current traces under control conditions and after 10 µM ICA for tetramers containing the indicated number and orientation of WT and F557L subunits. (B) Normalized Itest-Vt relationships for concatenated tetramers measured in the presence of 30 µM ICA (n = 4–10). Currents were normalized to the peak Itest under control conditions for each channel type. Symbol legends refer to data plotted in B, C, and G. (C) Correlation between log fold increase in Itest at 20 mV induced by 30 µM ICA and the number of WT subunits (i.e., number of functional ICA binding sites) in a concatenated tetramer. Data were fitted with a linear function: y = 0.36x + 0.1 (R2 = 0.94). (D) Fully activated Itail-Vret relationship for FL1/WT3 and FL1/WT1/FL2 tetramers before and after 30 µM ICA (n = 4). Currents were normalized to control Itail at −120 mV. (E) Voltage dependence of inactivation for FL1/WT3 and FL1/WT1/FL2 tetramers before and after 30 µM ICA (n = 4). V0.5inact and z values are presented in Table 2. (F) Effect of 30 µM ICA on the fully activated Itail-Vret relationships for WT4 channel currents recorded from oocytes bathed in a solution containing 20 mM KCl (n = 4). Data were normalized to Itail measured at −120 mV under control conditions. (G) Plot of calculated energy values, ΔΔG = |zFV0.5inact(30μM ICA)−zFV0.5inact(control)|, versus number of WT subunits contained in a concatenated tetramer compared with the relationships predicted for independent subunit transitions (▾) and cooperative subunit interactions, models 1 (▴) and 2 (•). Data are expressed as mean ± SEM (n = number of oocytes). Standard errors in zFV0.5inact were calculated as described previously (Yifrach and MacKinnon, 2002).

Abbruzzese, Modification of hERG1 channel gating by Cd2+. 2010, Pubmed, Xenbase

Abbruzzese, Modification of hERG1 channel gating by Cd2+. 2010, Pubmed , Xenbase
Andersen, Stoichiometry for activation of neuronal α7 nicotinic receptors. 2013, Pubmed
Bianchi, herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? 1998, Pubmed , Xenbase
Curran, A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. 1995, Pubmed
daCosta, Stoichiometry for drug potentiation of a pentameric ion channel. 2013, Pubmed
Fenichel, Drug-induced torsades de pointes and implications for drug development. 2004, Pubmed
Ficker, Molecular determinants of dofetilide block of HERG K+ channels. 1998, Pubmed , Xenbase
Garg, Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide. 2011, Pubmed , Xenbase
Gerlach, Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574). 2010, Pubmed
Goldin, Expression of ion channels by injection of mRNA into Xenopus oocytes. 1991, Pubmed , Xenbase
Hansen, Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). 2006, Pubmed , Xenbase
Hoshi, C-type inactivation of voltage-gated K+ channels: pore constriction or dilation? 2013, Pubmed
Hoshi, Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region. 1991, Pubmed , Xenbase
Huffaker, A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. 2009, Pubmed
Hurst, Potassium channel assembly from concatenated subunits: effects of proline substitutions in S4 segments. 1995, Pubmed , Xenbase
Hurst, Cooperative interactions among subunits of a voltage-dependent potassium channel. Evidence from expression of concatenated cDNAs. 1992, Pubmed , Xenbase
Imai, Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. 2009, Pubmed
Isacoff, Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes. 1990, Pubmed , Xenbase
Iyer, A computational model of the human left-ventricular epicardial myocyte. 2004, Pubmed
Kang, Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel. 2005, Pubmed
Keating, Molecular and cellular mechanisms of cardiac arrhythmias. 2001, Pubmed
MacKinnon, Functional stoichiometry of Shaker potassium channel inactivation. 1993, Pubmed , Xenbase
MacKinnon, Determination of the subunit stoichiometry of a voltage-activated potassium channel. 1991, Pubmed , Xenbase
McCormack, Tandem linkage of Shaker K+ channel subunits does not ensure the stoichiometry of expressed channels. 1992, Pubmed , Xenbase
Minier, Techniques: Use of concatenated subunits for the study of ligand-gated ion channels. 2004, Pubmed
MONOD, ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. 1965, Pubmed
Morrill, Isolation of a single carboxyl-carboxylate proton binding site in the pore of a cyclic nucleotide-gated channel. 1999, Pubmed , Xenbase
Ogielska, Cooperative subunit interactions in C-type inactivation of K channels. 1995, Pubmed , Xenbase
Panyi, C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. 1995, Pubmed
Perry, PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance. 2009, Pubmed , Xenbase
Perry, Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. 2007, Pubmed , Xenbase
Perutz, Stereochemistry of cooperative effects in haemoglobin. 1970, Pubmed
Sack, How to validate a heteromeric ion channel drug target: assessing proper expression of concatenated subunits. 2008, Pubmed
Sanguinetti, Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. 1990, Pubmed
Sanguinetti, A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. 1995, Pubmed , Xenbase
Schreibmayer, Voltage clamping of Xenopus laevis oocytes utilizing agarose-cushion electrodes. 1994, Pubmed , Xenbase
Sigworth, Voltage gating of ion channels. 1994, Pubmed
Smith, The inward rectification mechanism of the HERG cardiac potassium channel. 1996, Pubmed
Smith-Maxwell, Role of the S4 in cooperativity of voltage-dependent potassium channel activation. 1998, Pubmed , Xenbase
Spector, Fast inactivation causes rectification of the IKr channel. 1996, Pubmed , Xenbase
Stühmer, Electrophysiological recording from Xenopus oocytes. 1992, Pubmed , Xenbase
Trudeau, HERG, a human inward rectifier in the voltage-gated potassium channel family. 1995, Pubmed
Tytgat, Evidence for cooperative interactions in potassium channel gating. 1992, Pubmed , Xenbase
Weiss, The Hill equation revisited: uses and misuses. 1997, Pubmed
Yang, How does the W434F mutation block current in Shaker potassium channels? 1997, Pubmed , Xenbase
Yellen, An engineered cysteine in the external mouth of a K+ channel allows inactivation to be modulated by metal binding. 1994, Pubmed
Yifrach, Energetics of pore opening in a voltage-gated K(+) channel. 2002, Pubmed , Xenbase
Zagotta, Shaker potassium channel gating. III: Evaluation of kinetic models for activation. 1994, Pubmed , Xenbase
Zamorano-León, KCNH2 gene mutation: a potential link between epilepsy and long QT-2 syndrome. 2012, Pubmed
Zandany, Direct analysis of cooperativity in multisubunit allosteric proteins. 2008, Pubmed
Zhou, Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. 2005, Pubmed
Zou, A mutation in the pore region of HERG K+ channels expressed in Xenopus oocytes reduces rectification by shifting the voltage dependence of inactivation. 1998, Pubmed , Xenbase